Economic concerns about global healthcare in lung, head and neck cancer: Meeting the economic challenge of predictive, preventive and personalized medicine

EPMA Journal

Volumn 1, Issue 4, 2010, Pages 627-631

  Ausweger, Christine ^a   Burgschwaiger, Eva ^a   Kugler, Andrea ^a   Schmidbauer, Reinhard ^a   Steinek, Isabell ^a   Todorov, Yordan ^a   Thurnher, Dietmar ^b   Krapfenbauer, Kurt ^b  

^a VIENNA UNIVERSITY OF ECONOMICS AND BUSINESS   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Economic challenge; Head and neck cancer; In vitro diagnostics; Lung cancer; Prospective medicine

Indexed keywords

CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RISK; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CLINICAL PROTOCOL; EARLY DIAGNOSIS; ECONOMIC ASPECT; FINANCIAL MANAGEMENT; HEAD AND NECK CANCER; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH INSURANCE; HUMAN; LABORATORY DIAGNOSIS; LUNG CANCER; PATIENT CARE; PERSONALIZED MEDICINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 79953051533     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-010-0054-x     Document Type: Review

References (18)

1. Gupta PC, Pindborg JJ, Mehta FS. Comparison of carcinogenicity of betel quid with and without tobacco: an epidemiological review. Ecol Dis. 1982; 1: 213-9.
2. Fearlay J, Bray F, Pisani P, Parkin DM. Cancer incidence, mortality and prevalence worldwide. Version 1.0. IARC Cancer Base No. 5., IARC Press, Lyon; 2001.
3. European Lung Foundation, http://www. european-lung-foundation. org/index. php?id=65.
4. van Agthoven M, van Ineveld BM, de Boer MF, Leemans CR, Knegt PP, Snow GB, et al. The costs of head and neck oncology: primary tumors, recurrent tumors and long-term follow-up. Eur J Cancer. 2001; 37(17): 2204-11.
5. European diagnostics manufacturers association, http://www. edma-ivd. be/index. php?id=467.
6. Cancer Research, http://www. cancerhelp. org. uk/type/lung-cancer/about/lung-cancer-symptoms.
7. Immeasure, http://www. immeasure. com/Investor. htm.
8. Drugresearcher, http://www. drugresearcher. com/Research-management/Cancer-diagnostics-to-reach-7. 4-Billion-by-2009.
9. Business Insights (2009), The Cancer Market Outlook to 2014.
10. WHO, http://www. who. int/cancer/en/.
11. AKH consilium, http://akh-consilium. at/indikation/Malignome.
12. Österreichische Krebshilfe Wien, http://www. krebshilfe-wien. at/Frueherkennung. 99. 0. html.
13. Health-EU, http://ec. europa. eu/health/major_chronic_diseases/diseases/cancer/index_en. htm.
14. OeGHO, http://www. krebsfacharzt. at/ueber-krebs/lungenkrebs/lungenkrebs-im-ueberblick. html.
15. AKH consilium, http://akh-consilium. at/indikation/Bronchialkarzinom/Diagnose.
16. Mouth Cancer Foundation, http://www. rdoc. org. uk/.
17. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010; 46(4): 765-81.
18. The University of York (2004), http://www. york. ac. uk/inst/crd/EHC/ehc85. pdf.